- Home
- ABSI vs CAC Comparison
ABSI vs CAC Comparison
Compare ABSI & CAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ABSI | CAC |
|---|---|---|
| Founded | 2011 | 1875 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 997.8M | 876.2M |
| IPO Year | 2021 | 1996 |
Fundamental Metrics
Financial Performance| Metric | ABSI | CAC |
|---|---|---|
| Price | $6.53 | $51.93 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 2 |
| Target Price | $6.96 | ★ $47.00 |
| AVG Volume (30 Days) | ★ 4.5M | 73.8K |
| Earning Date | 05-07-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 3.51% |
| EPS Growth | ★ 10.64 | 6.08 |
| EPS | N/A | ★ 1.29 |
| Revenue | $4,534,000.00 | ★ $41,739,000.00 |
| Revenue This Year | $215.96 | $19.15 |
| Revenue Next Year | $319.10 | $6.05 |
| P/E Ratio | ★ N/A | $40.11 |
| Revenue Growth | N/A | ★ 16.96 |
| 52 Week Low | $2.24 | $35.00 |
| 52 Week High | $7.39 | $53.71 |
Technical Indicators
Market Signals| Indicator | ABSI | CAC |
|---|---|---|
| Relative Strength Index (RSI) | 57.46 | 64.75 |
| Support Level | $2.55 | $47.12 |
| Resistance Level | $7.06 | $53.71 |
| Average True Range (ATR) | 0.68 | 1.61 |
| MACD | -0.00 | 0.28 |
| Stochastic Oscillator | 62.05 | 96.77 |
Price Performance
Historical ComparisonAbout ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.
About CAC Camden National Corporation
Camden National Corporation is a banking solutions provider in the United States. Its core business is providing commercial banking products to individuals and corporates. Its consumer and commercial banking services entail services such as loans and deposits, savings and online banking, treasury management solutions and non-profit products to consumer, institutional, municipal, non-profit and commercial customers. The company also offers investment management and fiduciary services.